Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
An ongoing clinical trial is evaluating stereotactic body radiotherapy (SBRT) as a reirradiation approach for inoperable lung lesions in non…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009) [Phase 1]
Phase 1 study update of Calderasib (MK-1084) with Midazolam and Digoxin in healthy participants, status completed.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib [Phase 2]
Phase 2 study evaluating osimertinib plus savolitinib for EGFR-mutant, MET-positive non-small cell lung cancer after prior osimertinib, with…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Korea Post Marketing Surveillance (PMS) Study of Vizimpro
Pfizer reports the completion of the Korea post-marketing surveillance study of Vizimpro (dacomitinib) for non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC [Phase 2]
A Phase 2 neoadjuvant trial is comparing Serplulimab to Nivolumab in resectable stage II-IIIA squamous non-small cell lung cancer, and recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of tislelizumab monotherapy and tislelizumab-based combinations in resectable non-small cell lung cancer. The update reports o…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating NT-I7 (efineptakin alfa) in combination with pembrolizumab in adults with advanced solid tumors has completed and…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This completed open-label Phase 1/2 trial evaluated the combination of Itacitinib and Osimertinib in subjects with non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors [Phase 2]
A Phase 2 study evaluating vobramitamab duocarmazine in metastatic castration-resistant prostate cancer and other solid tumors was terminate…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 clinical trial evaluating radiation therapy to relieve symptoms in patients with advanced Non-Small Cell Lung Cancer has completed…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Intratumoral Cisplatin for Resectable NSCLC [Phase 1]
Phase 1 trial evaluating intratumoral cisplatin in patients with resectable non-small cell lung cancer has completed and results have been p…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients
Completed clinical trial investigating predictive immune biomarkers for atezolizumab therapy in patients with non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients [NA]
A Columbia University-sponsored clinical trial evaluating Apricity CARE to improve immune checkpoint inhibitor outcomes in ethnically/racial…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: PBF-1129 and Nivolumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial is evaluating PBF-1129 in combination with nivolumab for recurrent or metastatic non-small cell lung cancer and is currently…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene [Phase 2]
Phase 2 study of AB-106 in advanced non-small cell lung cancer with ROS1 fusions is listed as active but not currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen [Phase 1]
Phase 1 trial evaluating durvalumab with grid therapy for non-small cell lung cancer progressing during or after the PACIFIC regimen; the st…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: Expanded Access to Telisotuzumab Vedotin
AbbVie has opened Expanded Access for Telisotuzumab Vedotin to patients with non-small cell lung cancer. The program status is AVAILABLE.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MPDL3280A With Chemoradiation for Lung Cancer [Phase 2]
Phase 2 trial investigating atezolizumab (MPDL3280A) with chemoradiation for lung cancer (non-small cell lung cancer); current status is act…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Single Fraction Stereotactic Body Radiation Therapy After Surgery in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
Phase 1 clinical trial investigating single-fraction stereotactic body radiation therapy after surgery for non-small cell lung cancer; the s…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease [Phase 1]
This clinical trial update describes a Phase 1 study evaluating photodynamic therapy to amplify the response to immunotherapy in patients wi…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients [Phase 2]
A Phase 2 study evaluating the combination of osimertinib and aspirin in patients with EGFR-mutant non-small cell lung cancer (stage IV) has…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 2, Phase 3]
A completed phase 2/3 trial comparing tiragolumab plus atezolizumab with pemetrexed and platinum chemotherapy versus pembrolizumab plus peme…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy [Phase 3]
Phase 3 study evaluating tiragolumab plus atezolizumab versus placebo plus atezolizumab in completely resected non-small cell lung cancer af…
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
Phase 3 trial results compare lazertinib with subcutaneous amivantamab to intravenous amivantamab in patients with EGFR-mutated advanced or …
-
CLINICAL_TRIALS trial_result · 2026-02-02Clinical Trial Update: A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing lazertinib with subcutaneous amivantamab versus intravenous amivantamab in EGFR-mutated advanced or metastatic non…